CoChat

Pharmacokinetics of Fluconazole in Immune‐Compromised Children With Leukemia or Other Hematologic Disease

Seay, Russell E., Larson, Tom A., Toscano, John P., Bostrom, Bruce C., O'Leary, Maura C., Uden, Donald L. · 1995 · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Cited by 43

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Study Objective. To describe the pharmacokinetics of fluconazole in immune‐compromised children with leukemia or other hematologic disease. Design. Prospective. Setting. Children's Health Care‐Minneapolis hematology/oncology inpatient ward and outpatient clinic. Patients. Ten immune‐compromised children (mean ± SD age 7.4 ± 4.0 yrs, weight 31.6 ± 25.9 kg) with leukemia or other hematologic disease. Interventions. Serum was sampled before and after a single 6‐mg/kg intravenous dose and after seven oral 3‐mg/kg doses of fluconazole. Measurements and Main Results. Mean (SD) pharmacokinetics were distribution half‐life 1.67 (1.25) hours, elimination half‐life 15.62 (3.21) hours, total body clearance 0.63 (0.19) ml/min/kg, volume of distribution for the central compartment 0.56 (0.10) L/kg, volume of distribution at steady state 0.77 (0.12) L/kg, absorption half‐life 0.41 (0.26) hour, and oral bioavailability 0.92 (0.09). Volume of distribution for the central compartment was highly correlated with body surface area (r 2=0.891) and weight (r 2=0.949). Volume of distribution at steady state correlated with body surface area (r 2=0.986), and total body clearance correlated with body surface area (r 2=0.867). Conclusions. Fluconazole elimination was well described using a two‐compartment model. Oral absorption was rapid and nearly complete. Children have a larger volume of distribution for the central compartment and faster elimination rate than adults. Body surface area and weight are important factors in determining pharmacokinetics in these patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/j.1875-9114.1995.tb04331.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 43

Metadata

Authors
Seay, R. E., Larson, T. A., Toscano, J. P., Bostrom, B. C., O'Leary, M. C., & Uden, D. L.
Venue
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Publisher
Wiley
Published
1995-01-02
Volume
15
Issue
1
Pages
52-58
ISSN
  • 0277-0008 (ISSN-L)
  • 1875-9114
OpenAlex
W4388202839
Cited by
43
References
3
FWCI
1.21
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacokinetics of Fluconazole in Immune‐Compromised Children With Leukemia or Other Hematologic Disease. https://app.cochat.ai/papers/10.1002/j.1875-9114.1995.tb04331.x
The paper
Seay, R. E., Larson, T. A., Toscano, J. P., Bostrom, B. C., O'Leary, M. C., & Uden, D. L. (1995). Pharmacokinetics of Fluconazole in Immune‐Compromised Children With Leukemia or Other Hematologic Disease. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1002/j.1875-9114.1995.tb04331.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.